Home > Historical Performance > Historical Transaction Report

Transaction Details

Company: Cytyc
Ticker:cytc
Yahoo Beta:1.16
Industry:Medical instruments & supplies

Company Description:  Cytyc Corporation develops and sells a number of products that focus on women's health. The company has a large market share of cervical cancer screening tests, has a product for treating excessive menstrual bleeding, and is developing diagnostic tools and treatement for breast cancer.

Purchase Date:21 Feb 2007 Sale Date:22 Nov 2007
Purchase Price:$30.49 Sale Price:$34.13
  --Split Adjusted:$30.49  --Split Adjusted:$34.13
Shares Purchased:200 Shares Sold:200
  --Split Adjusted:200  --Split Adjusted:200
Transaction Fee:$159.11 Transaction Fee:$0.00
Price Range (6 Months Prior):    Price Range (6 Months After):    
High$30.73 High$0.00
Date16 Feb 2007 Date01 Feb 1996
Low$22.96 Low$0.00
Date03 Oct 2007 Date01 Feb 1996
S&P (Purchase Date):$1,459.68 S&P (Sale Date):$1,506.33

Purchase
Timing:  We bought near the six month high.
Reason:  The company has a small portfolio of successful products. They have a large proportion of the US thin prep cervical cancer screening market, and are expanding into Europe. Their other products are at an earlier stage, but are superior to existing products. We anticipate the company will grow significantly.

Sale
Timing:  
Reason:  CYTC was acquired by Hologic for a combination of cash and stock.

S&P Gain: 3.2 % Annualized Gain: 4.29%
Stock Gain: 11.93 % Annualized Gain: 16.2%

Dividends:$3,363.79
Net Holding Return ($): $3,932.20
Net Holding Return (%): 62.84 %